Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis.

Exclusion Criteria

• •Known allergy to any of the components in the investigational product.
• •Hypersensitivity against glycopyrrolate
• •Secondary hyperhidrosis, for example, hyperhidrosis that is secondary to other underlying diseases including hyperthyroidism, lymphoma and malaria, climacteric hyperhidrosis.
• •Previous surgical treatment of hyperhidrosis including sympathectomy, surgical debulking of the sweat glands, subcutaneous tissue curettage and ultrasonic surgery.
• •Botulinum toxin treatment in the prior 4 months.
• •Angle closure glaucoma or its precipitation (narrow angle).
• •Mycotic, other skin infections and other dermal disorder including infection at anticipated application sites in either axilla.
• •Any condition or situation that, in the investigator's or sub-investigator's opinion, may interfere with the patient's participation in the study;